STAT3 and epithelial-mesenchymal transitions in carcinomas - Wikidata - awgldk - TriplyDB

STAT3 and epithelial-mesenchymal transitions in carcinomas

STAT3 and epithelial-mesenchymal transitions in carcinomas

http://www.wikidata.org/entity/Q33623947

about

Regulation of Natural Killer Cell Function by STAT3 Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent.Expression of TWIST, an inducer of epithelial-mesenchymal transition, in nasopharyngeal carcinoma and its clinical significance.Expression and clinical significance of microvessel density and its association with TWIST in nasopharyngeal carcinoma Cisplatin-selected resistance is associated with increased motility and stem-like properties via activation of STAT3/Snail axis in atypical teratoid/rhabdoid tumor cells Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer.Inhibition of STAT3 reduces proliferation and invasion in salivary gland adenoid cystic carcinoma.Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers.Over-expression of TWIST, an epithelial-mesenchymal transition inducer, predicts poor survival in patients with oral carcinoma.Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancer Zinc transporter ZIP10 forms a heteromer with ZIP6 which regulates embryonic development and cell migration.Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.Expression and significance of TWIST, a zinc finger transcription factor, in laryngeal carcinoma among Chinese population: a meta-analysis Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.IL-17 induces EMT via Stat3 in lung adenocarcinoma Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinoma EFEMP1 promotes ovarian cancer cell growth, invasion and metastasis via activated the AKT pathway.NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-to-mesenchymal transition.Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.JAK inhibition and progressive kidney disease.Selective Inhibition of STAT3 Phosphorylation Using a Nuclear-Targeted Kinase Inhibitor.JAK1/STAT3 activation through a proinflammatory cytokine pathway leads to resistance to molecularly targeted therapy in non-small cell lung cancer.Metformin Inhibits Migration and Invasion of Cholangiocarcinoma Cells Role of STAT3 pathway in genitourinary tumors.MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factor.Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway.Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancer.Stress-induced EGF receptor signaling through STAT3 and tumor progression in triple-negative breast cancer.Overexpression of SPARC correlates with poor prognosis in patients with cervical carcinoma and regulates cancer cell epithelial-mesenchymal transition.Cancer cells remodel themselves and vasculature to overcome the endothelial barrier.Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways.LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation.Transforming growth factor β1 promotes migration and invasion in HepG2 cells: Epithelial‑to‑mesenchymal transition via JAK/STAT3 signaling.STAT3 polymorphism rs4796793 may be a predictive factor of tumor response to multiple tyrosine kinase inhibitors in metastatic renal cell carcinoma in Japanese population.Smad3-STAT3 crosstalk in pathophysiological contexts.JAK/STAT3 regulated global gene expression dynamics during late-stage reprogramming process.The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology.G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas.

P2860

Q26752551-1AE0E51D-F1E0-42E3-833A-CC26A689850D Q27330365-3E06D881-EE3A-42AD-8CEC-551CE8C03A1C Q35038550-1A24AAE7-F38F-4289-8590-8A109E6F16DE Q35173844-1F5C6A5E-E239-4E11-80E7-51130DA8DB16 Q35176432-C27108C5-77EA-4A2B-8DC0-19AC2C271DF8 Q35754295-5597EE90-1FE1-434C-A2A2-F17B1CCB1AD9 Q35835245-277F2DB7-058D-4724-9E53-0B3D29B6EF04 Q35952745-380F6680-C1AC-43FA-A913-C025A971E81E Q35958713-FACB3596-DCE5-4F66-84E9-AFEFFD91AE27 Q35992948-82594FFA-6A05-4795-852F-6576CE7C35C3 Q36044398-D06C4525-DD2C-4521-AC69-16FE9606BF2C Q36140818-8A6DC83D-755B-46A7-8A4C-E30954460427 Q36411828-41116222-3889-4DFC-8B84-0117BF477B9E Q36544477-B65A63C2-B410-46B6-9913-F29EC7AD4441 Q36878756-4B54210B-E8A5-45E5-BE07-A39CAF296E77 Q37349092-9549AE4A-5E6B-401E-B0D9-E66DAA519245 Q37565332-EBD23495-3A68-4276-A9D3-FAAE99EC0DF2 Q37576915-A9B3DFC0-3578-4DDD-8CBF-F4C9B7FE14EC Q37691632-1B9ECCDF-3249-448C-8E68-B1A7480917D7 Q37745906-76CD0E86-FB1E-4B6D-B6F2-84F94517A82D Q38270332-1E05A7D8-823D-4CF2-932E-89AB11862710 Q38634605-85D5376A-F100-4348-9F2F-41E1AE7F808E Q38669181-06BC56FF-3BFE-4DF2-B5F5-0B1B00901ADA Q38710382-C4F97DBC-D098-404F-B2D5-3942C604DF46 Q38776978-67864F4D-28FA-47D7-9555-AAC674D5010A Q38840848-B64C43E1-2167-4763-AF8C-E0486973CA20 Q38914414-B1DD8FB3-B3D4-404D-9FA8-DED39AAF0B1A Q38981044-25AD037D-EA1C-457D-AC24-962F3242613F Q39032755-5C7579AB-F507-4194-A987-10305E386207 Q39088864-8EC3AAF7-3B17-48B4-8345-B0EAB4DBC056 Q40500289-1CBA64DD-B02D-4AF9-A9D3-EA26EFD5342E Q41636608-310DE301-E0F5-49F8-B422-6D2B144AD0C1 Q42290800-EA5D10DC-7911-434C-AC32-79C86984F12E Q45074588-1C1680DE-086B-4F40-AFEE-41A5B316B90A Q47120426-8FC6DD31-1925-4422-AC83-0C1ABBE10717 Q48249432-F0F878DD-3D7E-4AD2-94F9-7F8851D3BBE2 Q50000565-08E4BF04-AA52-49C6-B8F1-DE02BD5EE4CC Q50420649-8FEC030E-56A1-4C98-8FC0-231074E3AAC5 Q55177212-AB75E007-F478-48D7-AD09-AFD89D6C4773 Q55346727-1BE1AFF2-0DAD-4F1C-83F4-BA6336399CD0

P2860

STAT3 and epithelial-mesenchymal transitions in carcinomas

http://www.wikidata.org/entity/Q33623947

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

STAT3 and epithelial-mesenchymal transitions in carcinomas

@ast

STAT3 and epithelial-mesenchymal transitions in carcinomas

@en

type

label

STAT3 and epithelial-mesenchymal transitions in carcinomas

@ast

STAT3 and epithelial-mesenchymal transitions in carcinomas

@en

prefLabel

STAT3 and epithelial-mesenchymal transitions in carcinomas

@ast

STAT3 and epithelial-mesenchymal transitions in carcinomas

@en

P1433

Q33623947-F2CB032E-5E03-441E-9EC7-B6076B630273

P1476

Q33623947-FDD843C5-A8DE-4CE3-B3FB-CC979B3EA8C9

P2093

Q33623947-375BED31-49C5-4AD6-8206-74B2CF54DE65

Q33623947-BEFA72FB-18CA-4250-9B96-22903291D0C3

Q33623947-CFF4735E-D04F-4E48-A134-A7746A717B9F

P2860

Q33623947-01FFF8D6-BB20-4C8A-B354-8E26F2142B90

Q33623947-06269D7F-2BAA-4F9A-81D2-55D7255D5526

Q33623947-08517C53-39F4-4FDA-9EA9-A971B76ED264

Q33623947-0D48E28A-CA3C-4A93-A217-B8DA7CAF3574

Q33623947-121958E3-E9C5-4D71-9548-2A9148C76749

Q33623947-1599BE5D-55FC-4049-A60C-C46E045E8D36

Q33623947-20AF9D7D-04F9-431F-9431-2B9BE22A9FCE

Q33623947-23093F89-5B48-4F92-9A20-2F381B252574

Q33623947-26582670-30AC-4B92-A8E8-860E95AEC5AD

Q33623947-292015C2-203A-4FFC-AE96-316CE93DE0E0

P304

Q33623947-F1CEDA2C-CEDA-4B3D-AE7E-F7C148AD79FA

P31

Q33623947-440B264F-8459-46C2-8A60-CE3A099BFEC5

P356

Q33623947-73494BC9-2940-484C-A32E-108723EE613D

P433

Q33623947-C6C95276-306D-4919-8384-23E93D5A61AA

P478

Q33623947-97A9EE81-FA85-4EBF-AD17-0439458865DB

P50

Q33623947-0EF98F33-E308-4D18-92C3-38689ABE15C9

P577

Q33623947-A9A1EDAF-9796-4A0B-8D52-20CE236399FE

P5875

Q33623947-C4FD8E9B-1028-4258-AA7E-005FC2F8698E

P698

Q33623947-00F56BEF-EA72-4B27-8648-AC48FE0F9A59

P932

Q33623947-CC55EB24-F156-4404-9A1D-7614E0114EAE

P356

P1433

P1476

STAT3 and epithelial-mesenchymal transitions in carcinomas

@en

P2093

Cathleen R Carlin

http://www.w3.org/2001/XMLSchema#string

Nikolas Balanis

http://www.w3.org/2001/XMLSchema#string

William P Schiemann

http://www.w3.org/2001/XMLSchema#string

P2860

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors.

STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression

The basics of epithelial-mesenchymal transition

Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression

Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

The Spemann organizer gene, Goosecoid, promotes tumor metastasis

SOCS, inflammation, and cancer

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

P304

e28975

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/JKST.28975

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Michael K Wendt

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262535120

http://www.w3.org/2001/XMLSchema#string

P698

24843831

http://www.w3.org/2001/XMLSchema#string

P932

4024059

http://www.w3.org/2001/XMLSchema#string